{"nct_id":"NCT05071053","title":"Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab in Pretreated Participants With Gastric Cancer","status":"TERMINATED","status_verified_date":"2025-08","start_date":"2021-11-16","start_date_type":"ACTUAL","primary_completion_date":"2023-06-23","primary_completion_date_type":"ACTUAL","completion_date":"2024-11-05","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["SNY"]}